[ Price : $8.95]
Regeneron Pharmaceuticals releases favorable Phase 3 data for its RNA-based therapy cemdisiran and says it will seek FDA approval ...[ Price : $8.95]
Eli Lilly plans to seek approval for its investigational obesity pill orforglipron following positive topline results from the Pha...[ Price : $8.95]
FDA warns North Brunswick, NJ-based LeMaitre Vascular about Quality System Regulation and other violations in its manufacturing of...[ Price : $8.95]
FDA grants fast track designation to Allarity Therapeutics investigational ovarian cancer drug stenoparib.[ Price : $8.95]
FDA extends by three months its review of an Axogen BLA for Avance Nerve Graft after the agency determined that information submit...[ Price : $8.95]
FDA warns Westborough, MA-based Miach Orthopaedics about eight Quality System and three Medical Device Reporting violations in its...[ Price : $8.95]
The Biotechnology Innovation Organization says its congressional lobbying priorities for September are reauthorization of the FDA ...[ Price : $8.95]
FDA warns Chinas Jiangsu Kerbio Technology Group Co. about its violations of good laboratory practice regulations for nonclinical ...